Hi,
12 months ago my dad was diagnosed with stage 4 metastatic adenocarcinoma of the lung. He has bone lesions, but no liver, brain or other metastases detected. He's been on a combination of paclitaxel+ gemcitabine+bevacizumab for the past year and, based on PET scans, it seems to be keeping him stable and holding back progression. In fact the main tumor and some of the bone metastases initially shrank somewhat.
He had the cobas EGFR mutation test, and the report just said "Exon 20 insertion detected." It didn't name which of the insertions that test can detect it was. Does this test reveal more specifics about the insertion, and the pathology lab were just being brief in the report, or is "exon 20 insertion detected" truly all the information that test can reveal?
If the latter, are there other EGFR tests that can give more details? Or detect other types of insertion than the 5 insertions the cobas test detects?
Thanks in advance for any help!
- Ben
PS I know that information isn't currently actionable, in that an exon 20 insertion doesn't indicate response to erlotinib/gefitinib. And so far so good on his current chemo regimen anyway. But we'd like to know as much as possible, in case new targeted treatments open up in the future.
Reply # - June 19, 2015, 07:39 AM
Hi Ben,
Hi Ben,
Welcome to GRACE. It's good to hear that your dad is responding well to treatment.
The cobas EGFR test can detect:
"41 mutations in exons 18 to 21 of the EGFR‑TK gene:
G719X (G719S/G719A/G719C) in exon 18
29 deletions and complex mutations in exon 19
T790M in exon 20
S768I in exon 20
5 insertions in exon 20
L858R in exon 21 (2 variants)"
according to information provided by the National Institute for Health and Care Excellence in Great Britain here.
In comparison testing with other test methods, the cobas test performed reliably:
http://www.ncbi.nlm.nih.gov/pubmed/23386666
http://www.ncbi.nlm.nih.gov/pubmed/24439568
For a great overview of EGFR mutations, Dr. Pennell wrote a very thorough post here.In the chart in that post, you'll see that there are a couple of uncommon exon 20 deletions which confer EGFR TKI sensitivity.
I think it's a pretty fair guess that the report was just a brief statement of the ultimate results.
Continued good luck with treatment.
JimC
Forum moderator
Reply # - June 19, 2015, 01:42 PM
Check this site also for more
Check this site also for more info. Take care, Judy
http://www.mycancergenome.org/content/disease/lung-cancer/egfr/64/
Reply # - June 19, 2015, 02:21 PM
Thanks for the replies! It
Thanks for the replies! It seemed odd to me that the test report laboriously listed each of the 41 mutations it can detect, but then didn't say which one it actually did detect, beyond that it was an exon 20 insertion. I can ask the pathology lab if they have more details internally, and I've emailed a couple of other test providers to see if their tests can discriminate a larger range of exon 20 insertions.
Reply # - June 19, 2015, 06:02 PM
hattrick, My wife has a HER2
hattrick, My wife has a HER2 mutation with exon 20 insertion. Is it possible you have the same?
Reply # - June 19, 2015, 06:06 PM
Sorry, I meant is it possible
Sorry, I meant is it possible your dad has a HER2 mutation?
Reply # - June 29, 2015, 02:18 PM
It's possible I suppose - I'm
It's possible I suppose - I'm not sure what role HER2 plays in NSCLC.
Reply # - June 29, 2015, 06:57 PM
Hi hattrick,
Hi hattrick,
Here's a GRACEcast video on the subject of HER2 in lung cancer: http://cancergrace.org/lung/2014/09/08/iaslc_gandhi_her2_drugs_help_lun…
JimC
Forum moderator